Spine device company NuVasive posted a $2.7 million loss in the fourth quarter of 2012, an improvement from the same time frame in 2011 when the company lost $10 million.
NuVasive's fourth quarter revenue jumped more than 10 percent, from $150 million to $165.8 million. Its year-end revenue also increased by nearly 15 percent from 2011, totaling $620 million from $540.5 million.
Some of the improvement can be tied to fewer fourth quarter operating expenses for impairment of goodwill and intangible assets, which the company spent $18 million on in 2011 and only $9.7 million on in 2012.
More Articles on Devices:
Amedica Artificial Disc Implant Granted Patent
Vexim Acquires Orthopedic Cement Injection Technology
MAKO Surgical Loses $5.7M in 4Q 2012 From Fewer Robotic Device Sales
Some of the improvement can be tied to fewer fourth quarter operating expenses for impairment of goodwill and intangible assets, which the company spent $18 million on in 2011 and only $9.7 million on in 2012.
More Articles on Devices:
Amedica Artificial Disc Implant Granted Patent
Vexim Acquires Orthopedic Cement Injection Technology
MAKO Surgical Loses $5.7M in 4Q 2012 From Fewer Robotic Device Sales